Julio Gonzalez japaoli19
8 years ago
Strong ACR20 W16 response after Filgotinib in PsA (16.9% TNFi failures)
#ACR18 @rheumnow https://t.co/kmOSQVRYdD
Julio Gonzalez japaoli19
8 years ago
PASI75/90 responses along with global pain reduction seen with oral Tyk2 inhibitor.
No changes on lab parameters, serious infections or thrombosis seen
#ACR18 @RheumNow https://t.co/N6LyXOd0an
William Shergy WilliamShergy
8 years ago
Lower the uric acid and save cognitive abilities. #ACR18 @RheumNow Abstract 2226. https://t.co/wtSxUg4NUL
Brittany A MissbeeMD
8 years ago
Always exciting to have new classification criteria presented at ACR.. while not diagnostic, can guide us to capture pts who need further eval & treatment!
Large vessel vasculitis, IgG4 related disease.
#ACR18 @RheumNow
William Shergy WilliamShergy
8 years ago
What to do when your SLE patient gets pregnant. #ACR18 @RheumNow Abstract 5T096 https://t.co/MsR0boQwRK
David Liew drdavidliew
8 years ago
Interesting data on PET/CT in GCA from Dr Sammel from Sydney incl some pickup of cranial GCA. Not replacing TABx totally but ?similar to MRI/USS with the plus of picking up infx/Ca, with same radiation as full CT. Aussies doing well with PET/CT @drceowen! #ACR18 ABSTL15 @RheumNow https://t.co/omhLbS1xbN
ǝlʇʇıɥʍ ɯɐs samwhittle
8 years ago
#ACR18 Late Breaking Abstracts
#L17 Bimekizumab (anti-IL17 A & F) in PsA. Superior ACR50 vs PBO at wk 12, increase in response to wk24, sustained to wk48. No major new safety signals (candida 5%, LFTs, 1 suicidal ideation).
Would be interesting to see vs IL17A alone.
@RheumNow https://t.co/r41yRb55Y7
Suleman Bhana, MD DrBhana
8 years ago
Nancy Baker on Challenges of Telehealth: Payers vary from state to state in the US (See figure) #ACR18 @RheumNow https://t.co/m17BUhKxIn
k dao KDAO2011
8 years ago
Why preconceptual counseling is so important even if patients are not currently sexually active! @rheumnow #acr18 https://t.co/UwKaQnAwZK
Suleman Bhana, MD DrBhana
8 years ago
Nancy Baker on Benefits of Telehealth:
-reduced health care costs
-improved access to care
-More productive workforce
-Better patient experience.
#ACR18 @RheumNow https://t.co/CJOZ5bX6vL
Olga Petryna DrPetryna
8 years ago
L17 Ph2 48 wk trial dual neutralization of IL‑17A and IL‑17F w/bezilkumab in PsA: at wk 12 ACR 50
And PASI and maintained at wk 48. Serious AEs around 4% at wks24&48, not dose related; most common nasopharyngitis. Oral candidiasis 10/206 (4.9%) at wk48 in BZK. #acr18 @rheumnow
Ian N Bruce Lupusdoc
8 years ago
#ACR18 @RheumNow abs 2418. This study from philadelphia is referring to only 47% of their sexually active women being on contraception and of the 53% not on contraception, 59% were on a potentially teratogenic med. https://t.co/90G6qNpKyO
William Shergy WilliamShergy
8 years ago
We need to worry more about our SLE patients and their bone loss. #ACR18 @RheumNow. Abstract 2327. https://t.co/vMDN2vtju8
William Shergy WilliamShergy
8 years ago
Peripheral vascular disease is associated with OP and hip fractures. #ACR18 @RheumNow Abstract 2305. https://t.co/VhFz3KzLNY
Suleman Bhana, MD DrBhana
8 years ago
Nancy Baker: Drivers of telehealth: lack of doctor access, advancements in tech (high speed internet), Affordable Care Act, patients more comfortable with digital medicine #ACR18 @RheumNow

